Slides: Why could patients with HF and T2DM benefit from SGLT2i?
Slides as educational service to PACE members and meeting participants
This lecture was part of a CME-accredited symposium "Heart Failure, diabetes & SGLT2i: Time to change practice?" held during Heart Failure 2019 in Athens, Greece. The presentation was prepared and held by prof. Martin Cowie is Cardiac Surgeon-scientist at St. Michael’s Hospital, Toronto, Canada